CARDLYTICS, INC. (CDLX) Operating margin 2016–2025
CARDLYTICS, INC. (CDLX) operating margin by fiscal year — reported operating income divided by reported revenue.
-48.0%FY2025 · since FY2016: -49.8% → -48.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -48.0% | +28.5 pp |
| FY2024 | -76.5% | -28.9 pp |
| FY2023 | -47.5% | +117.6 pp |
| FY2022 | -165.2% | -117.8 pp |
| FY2021 | -47.4% | -18.5 pp |
| FY2020 | -28.9% | -20.6 pp |
| FY2019 | -8.2% | +18.9 pp |
| FY2018 | -27.2% | -14.0 pp |
| FY2017 | -13.1% | +36.7 pp |
| FY2016 | -49.8% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CDLX financial trends
CDLX RevenueCDLX Net incomeCDLX Net marginCDLX Gross profitCDLX Gross marginCDLX Operating incomeCDLX Operating cash flowCDLX Free cash flowCDLX Capital expendituresCDLX Return on equityCDLX Stock buybacksCDLX Dividends paidCDLX Total assetsCDLX Total liabilitiesCDLX Shareholders’ equityCDLX overview →